High frequency of antidrug antibodies and association of random drug levels with efficacy in certolizumab pegol-treated patients with rheumatoid arthritis: results from the BRAGGSS cohort. (2017)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/annrheumdis-2015-208849
PubMed Identifier: 27245864
Publication URI: http://europepmc.org/abstract/MED/27245864
Type: Journal Article/Review
Volume: 76
Parent Publication: Annals of the rheumatic diseases
Issue: 1
ISSN: 0003-4967